Aquestive Therapeutics Stock In The News
| AQST Stock | USD 2.84 0.12 4.41% |
Our overall analysis of Aquestive Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Aquestive Therapeutics. The specific impact of Aquestive Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Aquestive Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Aquestive Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Aquestive Therapeutics Backtesting and Aquestive Therapeutics Hype Analysis. For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.
Aquestive |
Aquestive Therapeutics Today Top News and Investor Outlook
Aquestive Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Aquestive and other traded companies coverage with news coverage. We help investors stay connected with Aquestive headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Aquestive Stock performance. Please note that trading solely based on the Aquestive Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Aquestive Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Aquestive earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Aquestive Therapeutics that are available to investors today. That information is available publicly through Aquestive media outlets and privately through word of mouth or via Aquestive internal channels. However, regardless of the origin, that massive amount of Aquestive data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aquestive Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aquestive Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aquestive Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aquestive Therapeutics alpha.
Aquestive Largest EPS Surprises
Earnings surprises can significantly impact Aquestive Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-07 | 2023-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2025-03-03 | 2024-12-31 | -0.1325 | -0.1607 | -0.0282 | 21 | ||
2024-03-05 | 2023-12-31 | -0.08 | -0.11 | -0.03 | 37 | ||
2023-05-02 | 2023-03-31 | -0.19 | -0.12 | 0.07 | 36 | ||
2023-11-06 | 2023-09-30 | -0.11 | -0.03 | 0.08 | 72 | ||
2022-11-01 | 2022-09-30 | -0.31 | -0.23 | 0.08 | 25 |
Aquestive Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Aquestive Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
10th of March 2025
Disposition of 2182 shares by Cassie Jung of Aquestive Therapeutics at 2.54 subject to Rul... at insidermonkey.com
7th of March 2025
Aquestive Therapeutics Inc Q4 2024 Earnings Call Highlights Strategic Advances Amid ... at finance.yahoo.com
5th of March 2025
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Pro... at globenewswire.com
4th of March 2025
Aquestive Therapeutics Inc Q4 2024 Everything You Need To Know Ahead Of Earnings at finance.yahoo.com
27th of February 2025
Xencor Reports Q4 Loss, Tops Revenue Estimates at zacks.com
20th of February 2025
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business... at finance.yahoo.com
14th of February 2025
Aquestive Therapeutics, Inc.s high institutional ownership speaks for itself as stock cont... at simplywall.st
13th of January 2025
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives at gurufocus.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aquestive Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aquestive Therapeutics' short interest history, or implied volatility extrapolated from Aquestive Therapeutics options trading.
Additional Tools for Aquestive Stock Analysis
When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.